Showing results (71-80 of 174) with videos related to
Sort By:
Pageof 18
Annals of Hematology|January 26, 2008
The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantationFrank Neumann, Oliver Lobitz, Roland Fenk, et al.European Journal of Radiology Open|January 13, 2025
The predictive power of baseline metabolic and volumetric [<sup>18</sup>F]FDG PET parameters with different thresholds for early therapy failure and mortality risk in DLBCL patients undergoing CAR-T-cell therapyEmil Novruzov, Helena A Peters, Kai Jannusch, et al.Scientific Reports|November 20, 2025
Early CMV DNAemia during letermovir prophylaxis predicts lower risk of late CMV infection and is associated with enhanced T-cell immunity after alloHSCTTimothé Duplessix, Ben-Niklas Baermann, Alexander Sebastian Hölscher, et al.Archives of Neurology|November 16, 2011
Natalizumab and impedance of the homing of CD34+ hematopoietic progenitorsChristian Saure, Clemens Warnke, Fabian Zohren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationRafael F Duarte, Carmen Canals, Francesco Onida, et al.European Journal of Haematology|March 13, 2003
Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantationFrank Neumann, Caroline Herold, Barbara Hildebrandt, et al.Ejhaem|September 2, 2025
Early Free Light-Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA-Directed CAR-T CellsTim Richardson, Hishan Tharmaseelan, Guido Kobbe, et al.Annals of Hematology|April 12, 2026
Influence of different therapy strategies in patients with myelodysplastic neoplasms (MDS) on overall survival with regard to different decades: data from the German MDS registryJonas Welsch, Felicitas Schulz, Annika Kasprzak, et al.Annals of Hematology|November 20, 2017
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupThomas Schroeder, Christina Rautenberg, William Krüger, et al.International Journal of Cancer|July 9, 2016
Lenalidomide consolidation treatment in patients with multiple myeloma suppresses myelopoieses but spares erythropoiesisChristian Matthias Wilk, Niklas Heinzler, Amelie Boquoi, et al.Pageof 18